Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-03-15Clinical Trial Update: ABT-751 in Treating Young Patients With Refractory Solid Tumors [Phase 1]
A Phase 1 clinical trial of ABT-751 in children with refractory solid tumors has completed.
-
CLINICAL_TRIALS trial_result · 2012-03-15Clinical Trial Update: Talabostat Combined With Temozolomide or Carboplatin in Treating Young Patients With Relapsed or Refractory Brain Tumors or Other Solid Tumors [Phase 1]
Phase 1 trial evaluating talabostat in combination with temozolomide or carboplatin in pediatric patients with relapsed or refractory brain …
-
CLINICAL_TRIALS trial_result · 2012-03-15Clinical Trial Update: Ixabepilone in Treating Young Patients With Solid Tumors or Leukemia That Haven't Responded to Therapy [Phase 1]
Phase 1 pediatric trial update reports initial safety and dosing information for ixabepilone in children with relapsed or refractory solid t…
-
CLINICAL_TRIALS research · 2012-02-28Clinical Trial Update: Treated Blood Cells, Cyclophosphamide, Fludarabine Phosphate, and Aldesleukin in Treating Patients With Cancer [Phase 1]
A Phase 1 clinical trial evaluating cyclophosphamide, fludarabine phosphate, aldesleukin, and treated blood cells in various cancers was ter…
-
CLINICAL_TRIALS research · 2012-02-27Clinical Trial Update: Potential Biomarkers for Bevacizumab-Induced High Blood Pressure in Patients With Solid Tumor
Clinical trial update on potential biomarkers for bevacizumab-induced hypertension in patients with solid tumors; the study has been termina…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-02-15Clinical Trial Update: Effectiveness of MORAb-003 in Women With Ovarian Cancer Who Have Relapsed After Platinum-Based Chemotherapy [Phase 2]
A Phase 2 study evaluating MORAb-003 (farletuzumab) for women with ovarian cancer that relapsed after platinum-based chemotherapy has comple…
-
CLINICAL_TRIALS trial_result · 2012-02-09Clinical Trial Update: Diagnostic Imaging of Lymph Nodes in Gynaecologic Oncology
The update reports the completion of a clinical trial evaluating diagnostic imaging of lymph nodes in gynecologic cancers. The study examine…
-
CLINICAL_TRIALS trial_result · 2012-02-07Clinical Trial Update: UMCC 003 Cancer-Related Protein Biomarkers in Blood and Tumor Tissue of Patients With Cancer
Update on the UMCC 003 trial investigating cancer-related protein biomarkers in blood and tumor tissue across several cancers, with the stud…
-
CLINICAL_TRIALS trial_result · 2012-02-06Clinical Trial Update: Paclitaxel and CBT-1(Registered Trademark) to Treat Solid Tumors [NA]
This completed clinical trial evaluated paclitaxel in combination with CBT-1 for solid tumors, including cervical and ovarian cancers, with …
-
CLINICAL_TRIALS trial_result · 2012-02-02Clinical Trial Update: Safety and Tolerability Study of TAK-165 in Subjects With Tumors Expressing HER2 [Phase 1]
This Phase 1 safety and tolerability study of TAK-165 in patients with HER2-expressing tumors has completed, reporting on safety and tolerab…
-
CLINICAL_TRIALS trial_result · 2012-02-01Clinical Trial Update: Pharmacokinetic Study on the Administration of Nadroparin Dosing Serum HGF in Gynecological Patients
A pharmacokinetic study evaluated nadroparin dosing and associated serum HGF levels in gynecologic female patients; the study has completed.
-
CLINICAL_TRIALS trial_result · 2012-01-26Clinical Trial Update: Chemotherapy Drug Sensitivity Microculture (MiCK) Assay for Apoptosis [Phase 2, Phase 3]
Clinical trial update on the Chemotherapy Drug Sensitivity Microculture (MiCK) Assay for detecting chemotherapy-induced apoptosis across pha…
-
CLINICAL_TRIALS trial_result · 2012-01-20Clinical Trial Update: A Phase 2 Study of Oral MKC-1 in Patients With Ovarian or Endometrial Cancer [Phase 2]
Phase 2 study of oral MKC-1 in patients with ovarian or endometrial cancer has completed. The trial was sponsored by CASI Pharmaceuticals.
-
CLINICAL_TRIALS trial_result · 2012-01-10Clinical Trial Update: Tirapazamine Plus Cisplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial or Primary Peritoneal Cancer [Phase 2]
Phase 2 trial evaluating tirapazamine plus cisplatin for persistent or recurrent ovarian cancer or primary peritoneal cancer has completed.
-
CLINICAL_TRIALS trial_result · 2012-01-09Clinical Trial Update: Pilot Study to Evaluate 18F-fluorodeoxyglucose (FDG) Positron Emission Tomography /Computed Tomography (PET/CT) in Prediction of Early Response to Chemotherapy in Ovarian Cancer. [EARLY_Phase 1]
A pilot Phase 1 study evaluating whether FDG-PET/CT can predict early chemotherapy response in ovarian cancer; the trial status is completed…
-
CLINICAL_TRIALS trial_result · 2011-12-13Clinical Trial Update: Antitumoral Activity and Safety of AEZS-108 in Women With LHRH Receptor Positive Gynecological Tumors [Phase 2]
Phase 2 trial evaluating antitumor activity and safety of AEZS-108 in LHRH receptor–positive gynecological tumors (ovarian and endometrial c…
-
CLINICAL_TRIALS trial_result · 2011-11-30Clinical Trial Update: Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell Transplantation [Phase 2]
This clinical trial update reports results from a Phase 2 study of lymphocyte infusion for patients who relapsed cancer after bone marrow or…
-
CLINICAL_TRIALS trial_result · 2011-11-18Clinical Trial Update: Efficacy Multicentre Trial of ImmunoTherapy Vaccination With Abagovomab to Treat Ovarian Cancer Patients [Phase 2, Phase 3]
A multicentre Phase 2/Phase 3 trial evaluating Abagovomab as an immunotherapy vaccine for ovarian cancer has been terminated; results were p…
-
CLINICAL_TRIALS trial_result · 2011-11-10Clinical Trial Update: Study of the mTOR Inhibitor Temsirolimus (CCI-779) to Treat Ovarian Cancer With CA125 Only Relapse [Phase 2]
Phase 2 study of temsirolimus (CCI-779) for ovarian cancer with CA125-only relapse was terminated.
-
CLINICAL_TRIALS research · 2011-11-08Clinical Trial Update: Risk of Ovarian Cancer in Patients With a Pelvic Mass
This clinical trial update reports on the risk of ovarian cancer in patients with a pelvic mass; the study has completed.
-
CLINICAL_TRIALS research · 2011-11-07Clinical Trial Update: Epidemiology of Ovarian Cancer in Taiwan
Clinical trial update examining the epidemiology of ovarian cancer in Taiwan, including incidence and trends. It may address risk factors an…
-
CLINICAL_TRIALS trial_result · 2011-11-03Clinical Trial Update: A Study of Carboplatin and Gemcitabine Plus Bevacizumab in Patients With Ovary, Peritoneal, or Fallopian Tube Carcinoma [Phase 3]
A Phase 3 trial of carboplatin and gemcitabine plus bevacizumab in ovarian, fallopian tube, or primary peritoneal cancer has completed and p…
-
CLINICAL_TRIALS trial_result · 2011-10-24Clinical Trial Update: Safety/Efficacy Study of SGN-15 (Antibody-Drug Conjugate) Combined With Gemcitabine in Patients With Ovarian Cancer [Phase 2]
A Phase 2 safety/efficacy study of SGN-15 in combination with gemcitabine for ovarian cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2011-10-20Clinical Trial Update: Study of OSI-211 vs. Topotecan in Patients With Relapsed Epithelial Ovarian Cancer [Phase 2]
A Phase 2 study comparing OSI-211 with topotecan in relapsed epithelial ovarian cancer has completed.
-
CLINICAL_TRIALS trial_result · 2011-10-12Clinical Trial Update: Abraxane Plus Carboplatin for Recurrent Platinum-Sensitive Ovarian Cancer [Phase 2]
A phase 2 study evaluating Abraxane (nab-paclitaxel) in combination with carboplatin for recurrent platinum-sensitive ovarian cancer has com…